BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2019
View Archived Issues
Viral-MS link comes via bad memories
Read More
Gut microbiome affects food allergies
Read More
Glucagon alpha-cell proliferation declines with age
Read More
Dengue virus protein mutation increases disease severity in mice
Read More
Patient enrollment ongoing in phase I study of MBS-301
Read More
New phase IIa ELEVATE 1 study investigates RVT-1201 for pulmonary arterial hypertension
Read More
Janssen Pharmaceutica presents PRMT5 inhibitors
Read More
First patient enrolled in IBT's pivotal phase III study of IBP-9414
Read More
NeuroVive announces the initiation of the second part of its ongoing phase Ia/b study of KL-1333
Read More
Nosopharm and Evotec partner to advance development of novel antibiotics
Read More
Vaccex to initiate clinical development of VX-001
Read More
Novel ERB antibiotics show promising activity in MRSA thigh infection models
Read More
LSS biallelic pathogenic variants are associated with APMR syndrome
Read More
Novel genetic variant in CARD11 as a biomarker of profound combined immunodeficiency
Read More
SP-8356, a CD147 inhibitor, is a potential compound for treating atherosclerosis
Read More
Aquaporin-1 is a potential therapeutic target in TBI, researchers find
Read More
Bristol-Myers Squibb patents TLR7, TLR8 and/or TLR9 antagonists
Read More
Janssen Biotech patent describes hSTING agonists
Read More
REVOLUTION Medicines identifies PTPN11 inhibitors
Read More
Pyramid Biosciences synthesizes NTRK1 inhibitors
Read More
Innovate UK grant supports ROP cancer vaccine development
Read More
FDA approves Xembify for primary immunodeficiencies
Read More
WDFY3 gene variants linked to mild to moderate neurodevelopmental delay and intellectual disability
Read More
Lasmiditan for acute treatment of migraine: results from phase III trial
Read More
EMA validates clinical development program for AB-8939
Read More
